Clinical Trial Update: Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating a subcutaneous progestogen implant for medical management of painful endometriosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Snippet

Sponsor: Centre Hospitalier Universitaire de la Réunion | Conditions: Endometriosis | Phase 2, Phase 3 | Status: TERMINATED